{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:15:24Z","timestamp":1793319324763,"version":"4.5.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Vernal keratoconjunctivitis (VKC) is an underdiagnosed and underrecognized ocular surface disease with limited epidemiological data in Asia. It is more prevalent in warm, dry, and windy climates, and often has a substantial impact on a patient\u2019s quality of life. In rare cases, VKC can be associated with vision loss, either through corticosteroid overuse or inadequate treatment of persistent inflammation. As a potentially severe and complex disease, there is variability with how VKC is managed across Asia and among the various allergic eye diseases. Diagnosis and treatment of patients with VKC is a challenge for many ophthalmologists, since no precise diagnostic criteria have been established, the pathogenesis of the disease is unclear, and anti-allergic treatments are often ineffective in patients with moderate or severe disease. In addition, the choice of treatment and management strategies used for patients varies greatly from country to country and physician to physician. This may be because of a lack of well-defined, standardized guidelines. In response, the Management of Vernal Keratoconjunctivitis in Asia (MOVIA) Expert Working Group (13 experts) completed a consensus program to evaluate, review, and develop best-practice recommendations for the assessment, diagnosis, and management of VKC in Asia. The expert-led recommendations are summarized in this article and based on the currently available evidence alongside the clinical expertise of ophthalmologists from across Asia with specialism and interest in the ocular surface, VKC, and pediatric ophthalmology.<\/jats:p>","DOI":"10.3389\/fmed.2022.882240","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T04:26:52Z","timestamp":1659328012000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Diagnosis, Management, and Treatment of Vernal Keratoconjunctivitis in Asia: Recommendations From the Management of Vernal Keratoconjunctivitis in Asia Expert Working Group"],"prefix":"10.3389","volume":"9","author":[{"given":"Jodhbir S.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur C. K.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Xuan","family":"Cung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo J.","family":"Dualan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Kekunnaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurliza","family":"Khaliddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Im","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Wei","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Manurung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattaporn","family":"Tesavibul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bremond-Gignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40123-013-0019-y","article-title":"Management of vernal keratoconjunctivitis.","volume":"2","author":"Leonardi","year":"2013","journal-title":"Ophthalmol Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/iid3.278","article-title":"Role of ocular cytology in vernal keratoconjunctivitis.","volume":"8","author":"Bruschi","year":"2020","journal-title":"Immun Inflamm Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/OPTH.S129552","article-title":"Vernal keratoconjunctivitis.","volume":"12","author":"Addis","year":"2018","journal-title":"Clin Ophthalmol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.eye.6700675","article-title":"Vernal keratoconjunctivitis.","volume":"18","author":"Bonini","year":"2004","journal-title":"Eye."},{"key":"B5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/ACI.0000000000000204","article-title":"Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study.","volume":"15","author":"Leonardi","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5415\/apallergy.2011.1.3.108","article-title":"Ocular allergy in the Asia Pacific region.","volume":"1","author":"Katelaris","year":"2011","journal-title":"Asia Pac Allergy."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-019-0656-4","article-title":"Vernal keratoconjunctivitis: an update focused on clinical grading system.","volume":"45","author":"Zicari","year":"2019","journal-title":"Ital J Pediatr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.alit.2020.06.004","article-title":"Epidemiological aspects of allergic conjunctivitis.","volume":"69","author":"Miyazaki","year":"2020","journal-title":"Allergol Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1136\/bjo.2007.117812","article-title":"Prevalence of vernal keratoconjunctivitis: a rare disease?","volume":"92","author":"Bremond-Gignac","year":"2008","journal-title":"Br J Ophthalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/s0161-6420(00)00092-0","article-title":"Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup.","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/srep23858","article-title":"Ambient air pollution, weather changes, and outpatient visits for allergic conjunctivitis: a retrospective registry study.","volume":"6","author":"Hong","year":"2016","journal-title":"Sci Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5415\/apallergy.2017.7.2.57","article-title":"Allergic conjunctivitis in Asia.","volume":"7","author":"Thong","year":"2017","journal-title":"Asia Pac Allergy."},{"key":"B13","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jaci.2005.05.033","article-title":"CCR4 and CCR5 expression in conjunctival specimens as differential markers of T(H)1\/T(H)2 in ocular surface disorders.","volume":"116","author":"Baudouin","year":"2005","journal-title":"J Allergy Clin Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/187221311794474883","article-title":"Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.","volume":"5","author":"Mishra","year":"2011","journal-title":"Recent Pat Inflamm Allergy Drug Discov."},{"key":"B15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1350-9462(02)00006-X","article-title":"Vernal keratoconjunctivitis: pathogenesis and treatment.","volume":"21","author":"Leonardi","year":"2002","journal-title":"Prog Retin Eye Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ajo.2007.06.028","article-title":"Development and testing of the quality of life in children with vernal keratoconjunctivitis questionnaire.","volume":"144","author":"Sacchetti","year":"2007","journal-title":"Am J Ophthalmol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0161-6420(95)30925-6","article-title":"Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis.","volume":"102","author":"Cameron","year":"1995","journal-title":"Ophthalmology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ajo.2012.09.014","article-title":"Management, clinical outcomes, and complications of shield ulcers in vernal keratoconjunctivitis.","volume":"155","author":"Reddy","year":"2013","journal-title":"Am J Ophthalmol."},{"key":"B19","first-page":"88","article-title":"Ocular complications of vernal keratoconjunctivitis.","volume":"34","author":"Tabbara","year":"1999","journal-title":"Can J Ophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.4103\/ijo.IJO_2143_18","article-title":"Pattern of steroid misuse in vernal keratoconjunctivitis resulting in steroid induced glaucoma and visual disability in Indian rural population: an important public health problem in pediatric age group.","volume":"67","author":"Sen","year":"2019","journal-title":"Indian J Ophthalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.eye.6702816","article-title":"Perilimbal conjunctival pigmentation in Chinese patients with vernal keratoconjunctivitis.","volume":"22","author":"Luk","year":"2008","journal-title":"Eye."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2016.0005","article-title":"Atopic and vernal keratoconjunctivitis: differences and similarities.","volume":"94","author":"Bremond-Gignac","year":"2016","journal-title":"Acta Ophthalmologica."},{"key":"B23","first-page":"S21","article-title":"Allergic conjunctivitis.","volume":"31","author":"Rathi","year":"2016","journal-title":"Comm Eye Health South Asia."},{"key":"B24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jtos.2019.07.004","article-title":"Adult vernal keratoconjunctivitis: clinical and biochemical profile of a rare disease.","volume":"17","author":"Di Zazzo","year":"2019","journal-title":"Ocul Surf."},{"key":"B25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/0301-4738.179727","article-title":"Systematic approach to managing vernal keratoconjunctivitis in clinical practice: severity grading system and a treatment algorithm.","volume":"64","author":"Gokhale","year":"2016","journal-title":"Indian J Ophthalmol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5005\/jp-journals-l0028-1226","article-title":"Steroid-induced glaucoma: an avoidable irreversible blindness.","volume":"11","author":"Phulke","year":"2017","journal-title":"J Curr Glaucoma Pract."},{"key":"B27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/ACI.0b013e3282efb726","article-title":"Clinical grading of vernal keratoconjunctivitis.","volume":"7","author":"Bonini","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1111\/all.13786","article-title":"Management of ocular allergy.","volume":"74","author":"Leonardi","year":"2019","journal-title":"Allergy."},{"key":"B29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.alit.2016.12.004","article-title":"Japanese guidelines for allergic conjunctival diseases 2017.","volume":"66","author":"Takamura","year":"2017","journal-title":"Allergol Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1111\/all.13178","article-title":"Diagnostic tools in ocular allergy.","volume":"72","author":"Leonardi","year":"2017","journal-title":"Allergy."},{"key":"B31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ophtha.2015.07.012","article-title":"Atopic keratoconjunctivitis in children: clinical features and diagnosis.","volume":"123","author":"Bremond-Gignac","year":"2016","journal-title":"Ophthalmology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.alit.2020.03.005","article-title":"Japaense guidelines for allergic conjunctival disease 2020.","volume":"69","author":"Miyazaki","year":"2020","journal-title":"Allergol Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ajo.2011.08.037","article-title":"Severity of pediatric blepharoconjunctivitis in Asian eyes.","volume":"153","author":"Teo","year":"2012","journal-title":"Am J Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.ophtha.2007.01.021","article-title":"Visual outcome and corneal changes in children with chronic blepharokeratoconjunctivitis.","volume":"114","author":"Jones","year":"2007","journal-title":"Ophthalmology."},{"key":"B35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1600-0420.2006.00665.x","article-title":"Subconjunctival crystals in paediatric blepharokeratoconjunctivitis.","volume":"84","author":"Mehta","year":"2006","journal-title":"Acta Ophthalmol Scand."},{"key":"B36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.survophthal.2018.12.003","article-title":"The persistent dilemma of microbial keratitis: global burden, diagnosis, and antimicrobial resistance.","volume":"64","author":"Ung","year":"2019","journal-title":"Surv Ophthalmol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/cea.12264","article-title":"An essential role for dendritic cells in vernal keratoconjunctivitis: analysis by laser scanning confocal microscopy.","volume":"44","author":"Liu","year":"2014","journal-title":"Clin Exp Allergy."},{"key":"B38","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S1081-1206(10)61958-8","article-title":"Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.","volume":"89","author":"Pucci","year":"2002","journal-title":"Ann Allergy Asthma Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1136\/bjophthalmol-2017-311171","article-title":"Corneal staining patterns in vernal keratoconjunctivitis: the new VKC-CLEK scoring scale.","volume":"102","author":"Leonardi","year":"2018","journal-title":"Br J Ophthalmol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/archopht.117.5.643","article-title":"Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs.","volume":"117","author":"Yanni","year":"1999","journal-title":"Arch Ophthalmol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1600-0420.1999.tb01171.x","article-title":"A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs.","volume":"228","author":"Yanni","year":"1999","journal-title":"Acta Ophthalmol Scand Suppl."},{"key":"B42","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1590\/S0004-27492006000600013","article-title":"Compara\u00e7\u00e3o entre o uso t\u00f3pico do fumarato de cetotifeno 0,025% e do cloridrato de olopatadina 0,1% no tratamento da ceratoconjuntivite primaveril [comparative study between 0.025% ketotifen fumarate and 0.1% olopatadine hydrochloride in the treatment of vernal keratoconjunctivitis].","volume":"69","author":"Hida","year":"2006","journal-title":"Arq Bras Oftalmol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejpb.2017.03.006","article-title":"Cyclosporine A delivery to the eye: a comprehensive review of academic and industrial efforts.","volume":"117","author":"Lallemand","year":"2017","journal-title":"Eur J Pharm Biopharm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2147\/OPTH.S181811","article-title":"Eye drop emulsion containing 0.1% cyclosporin (1 mg\/mL) for the treatment of severe vernal keratoconjunctivitis: an evidence-based review and place in therapy.","volume":"13","author":"Nebbioso","year":"2019","journal-title":"Clin Ophthalmol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/604204","article-title":"Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.","volume":"2012","author":"Lallemand","year":"2012","journal-title":"J Drug Dev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.ophtha.2013.03.044","article-title":"Topical cyclosporine in the treatment of allergic conjunctivitis: a meta-analysis.","volume":"120","author":"Wan","year":"2013","journal-title":"Ophthalmology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ajo.2019.11.020","article-title":"Twelve-month results of cyclosporine a cationic emulsion in a randomized study in patients with pediatric vernal keratoconjunctivitis.","volume":"212","author":"Bremond-Gignac","year":"2020","journal-title":"Am J Ophthalmol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ophtha.2018.12.027","article-title":"A randomized, controlled trial of cyclosporine a cationic emulsion in pediatric vernal keratoconjunctivitis: the VEKTIS study.","volume":"126","author":"Leonardi","year":"2019","journal-title":"Ophthalmology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/0974-9233.164616","article-title":"Tacrolimus ointment for treatment of vernal keratoconjunctivitis.","volume":"23","author":"Al-Amri","year":"2016","journal-title":"Middle East Afr J Ophthalmol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5935\/0004-2749.20170038","article-title":"Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial.","volume":"80","author":"M\u00fcller","year":"2017","journal-title":"Arq Bras Oftalmol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5935\/0004-2749.20190026","article-title":"Long-term use of topical tacrolimus ointment: a safe and effective option for the treatment of vernal keratoconjunctivitis.","volume":"82","author":"M\u00fcller","year":"2019","journal-title":"Arq Bras Oftalmol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/jop.2009.0087","article-title":"A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis.","volume":"26","author":"Ohashi","year":"2010","journal-title":"J Ocul Pharmacol Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1097\/ICO.0000000000000918","article-title":"Tacrolimus in corticosteroid-refractory vernal keratoconjunctivitis.","volume":"35","author":"Chatterjee","year":"2016","journal-title":"Cornea."},{"key":"B54","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00417-019-04287-1","article-title":"Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.","volume":"257","author":"Liu","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B55","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/bjophthalmol-2013-304453","article-title":"Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement.","volume":"98","author":"Fukushima","year":"2014","journal-title":"Br J Ophthalmol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/b978-012370585-3.50012-1","author":"Niederkorn","year":"2008","journal-title":"Immune System and the Eye Ocular Therapeutics."},{"key":"B57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","article-title":"Locally administered ocular corticosteroids: benefits and risks.","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf."},{"key":"B58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9394(14)70271-5","article-title":"Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis.","volume":"121","author":"Holsclaw","year":"1996","journal-title":"Am J Ophthalmol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10792-011-9421-4","article-title":"Supratarsal injection of triamcinolone acetonide and childhood allergic keratoconjunctivitis.","volume":"32","author":"Zaouali","year":"2012","journal-title":"Int Ophthalmol."},{"key":"B60","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0091-6749(94)90081-7","article-title":"Conjunctivitis medicamentosa.","volume":"94","author":"Spector","year":"1994","journal-title":"J Allergy Clin Immunol."},{"key":"B61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003495-200565020-00004","article-title":"Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis.","volume":"65","author":"Bielory","year":"2005","journal-title":"Drugs."},{"key":"B62","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1365-2222.2011.03835.x","article-title":"Sublingual immunotherapy for allergic conjunctivitis: cochrane systematic review and meta-analysis.","volume":"41","author":"Calderon","year":"2011","journal-title":"Clin Exp Allergy."},{"key":"B63","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jfma.2012.07.017","article-title":"Surgical management and immunohistochemical study of corneal plaques in vernal keratoconjunctivitis.","volume":"112","author":"Lin","year":"2013","journal-title":"J Formos Med Assoc."},{"key":"B64","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/112067210801800123","article-title":"Superficial keratectomy and amniotic membrane patch in the treatment of corneal plaque of vernal keratoconjunctivitis.","volume":"18","author":"Pelegrin","year":"2008","journal-title":"Eur J Ophthalmol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/01.ico.0000121710.58571.c4","article-title":"Surgical management of corneal plaques in vernal keratoconjunctivitis: a clinicopathologic study.","volume":"23","author":"Solomon","year":"2004","journal-title":"Cornea."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-020-02407-8","article-title":"Surgical debridement of corneal shield ulcers in pediatric patients: two case reports and a review of the literature.","volume":"14","author":"Stock","year":"2020","journal-title":"J Med Case Rep."},{"key":"B67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/ojo.OJO_263_2018","article-title":"Management of vernal keratoconjunctivitis in children in Saudi Arabia.","volume":"13","author":"AlHaran","year":"2020","journal-title":"Oman J Ophthalmol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/01.ico.0000183533.14899.8d","article-title":"Quantitative evaluation of the early changes in ocular surface inflammation following MMC-aided papillary resection in severe allergic patients with corneal complications.","volume":"25","author":"Tanaka","year":"2006","journal-title":"Cornea."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/all.12009","article-title":"Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface.","volume":"67","author":"Leonardi","year":"2012","journal-title":"Allergy."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.882240\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T04:27:05Z","timestamp":1659328025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.882240\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":69,"alternative-id":["10.3389\/fmed.2022.882240"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.882240","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,1]]},"article-number":"882240"}}